Literature DB >> 8931333

Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria.

B J Wards1, D M Collins.   

Abstract

The effects of electroporation temperature, biochemical pretreatment of cells and stage of culture on electroporation efficiency for slow-growing mycobacteria were investigated. The efficiency of transformation into Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium intracellulare increased markedly with temperature. In contrast, the efficiency of transformation into Mycobacterium smegmatis, a fast-growing species, was higher at 0 degree C and decreased with temperature. While stage of culture had little effect, a further increase in efficiency of 2-4-fold was obtained following glycine or ethionamide pretreatment. Electroporation at 37 degrees C has been chosen as a standard condition for slow-growing species as it usually resulted in a transformation efficiency several orders of magnitude higher than that obtained at 0 degree C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931333     DOI: 10.1111/j.1574-6968.1996.tb08563.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  42 in total

1.  Mycobacterial infection of macrophages results in membrane-permeable phagosomes.

Authors:  R Teitelbaum; M Cammer; M L Maitland; N E Freitag; J Condeelis; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery.

Authors:  Meenakshi Balganesh; Sanjana Kuruppath; Nimi Marcel; Sreevalli Sharma; Anju Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

3.  Comparative analysis of mycobacterial truncated hemoglobin promoters and the groEL2 promoter in free-living and intracellular mycobacteria.

Authors:  Sunil V Joseph; G K Madhavilatha; R Ajay Kumar; Sathish Mundayoor
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

4.  Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.

Authors:  Jae-Sung Yu; James W Peacock; Stacie Vanleeuwen; Tsungda Hsu; William R Jacobs; Mark J Cayabyab; Norman L Letvin; Richard Frothingham; Herman F Staats; Hua-Xin Liao; Barton F Haynes
Journal:  Clin Vaccine Immunol       Date:  2006-08-30

5.  A novel cell wall lipopeptide is important for biofilm formation and pathogenicity of Mycobacterium avium subspecies paratuberculosis.

Authors:  Chia-wei Wu; Shelly K Schmoller; John P Bannantine; Torsten M Eckstein; Julia M Inamine; Michael Livesey; Ralph Albrecht; Adel M Talaat
Journal:  Microb Pathog       Date:  2009-02-05       Impact factor: 3.738

6.  UvrD2 is essential in Mycobacterium tuberculosis, but its helicase activity is not required.

Authors:  Alan Williams; Carolin Güthlein; Nicola Beresford; Erik C Böttger; Burkhard Springer; Elaine O Davis
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

7.  Isocitrate lyase encoding plasmids in BCG cause increased survival in ApoB100-only LDLR-/- mice.

Authors:  Agnes Mira Szabo; Valeria Endresz; Ferenc Somogyvari; Andras Miczak; Ildiko Faludi
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

8.  Development of rapid microwave-mediated and low-temperature bacterial transformations.

Authors:  Valerie T Tripp; Johnathan C Maza; Douglas D Young
Journal:  J Chem Biol       Date:  2013-05-21

9.  Molecular characterization of the eis promoter of Mycobacterium tuberculosis.

Authors:  Esteban A Roberts; Amanda Clark; Sarah McBeth; Richard L Friedman
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

10.  A replication clock for Mycobacterium tuberculosis.

Authors:  Wendy P Gill; Nada S Harik; Molly R Whiddon; Reiling P Liao; John E Mittler; David R Sherman
Journal:  Nat Med       Date:  2009-02-01       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.